Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Invested Capital (2019 - 2025)

Historic Invested Capital for Sotera Health (SHC) over the last 7 years, with Q3 2025 value amounting to $2.7 billion.

  • Sotera Health's Invested Capital fell 8.69% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 8.69%. This contributed to the annual value of $2.6 billion for FY2024, which is 166.12% down from last year.
  • Per Sotera Health's latest filing, its Invested Capital stood at $2.7 billion for Q3 2025, which was down 8.69% from $2.7 billion recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Invested Capital ranged from a high of $2.7 billion in Q2 2025 and a low of $2.3 billion during Q3 2021
  • In the last 5 years, Sotera Health's Invested Capital had a median value of $2.6 billion in 2023 and averaged $2.5 billion.
  • As far as peak fluctuations go, Sotera Health's Invested Capital skyrocketed by 1646.27% in 2023, and later tumbled by 166.12% in 2024.
  • Sotera Health's Invested Capital (Quarter) stood at $2.3 billion in 2021, then fell by 1.51% to $2.3 billion in 2022, then rose by 16.46% to $2.7 billion in 2023, then fell by 1.66% to $2.6 billion in 2024, then rose by 2.5% to $2.7 billion in 2025.
  • Its Invested Capital stands at $2.7 billion for Q3 2025, versus $2.7 billion for Q2 2025 and $2.6 billion for Q1 2025.